source
- FDA lifts opposition to Huntington’s disease gene therapy, clearing path for developmentThe Readout Loud podcast this week highlighted a regulatory shift for a gene therapy aimed at Huntington’s disease. The Food and Drug Administration reversed its earlier opposition, removing a key…
- FDA advisory panel unanimously backs Moderna’s flu vaccineThe FDA’s Vaccines and Related Biological Products Advisory Committee voted unanimously to recommend Moderna’s seasonal influenza vaccine. The vote overturns earlier hesitations from previous agen…